Canagliflozin tablets

Canagliflozin tablets

Form: Tablets

Strength: 100 mg and 300 mg

Reference Brands: Invokana(US & EU)

Category: Diabetes

Canagliflozin is an oral sodium-glucose co-transporter 2 (SGLT2) inhibitor used for managing type 2 diabetes and reducing cardiovascular and renal risks. Approved by the FDA in 2013 under the brand Invokana (100 mg, 300 mg), it received EU approval via centralized procedure the same year. It may be used as monotherapy or in combination with other antidiabetic agents. Canagliflozin lowers blood glucose by promoting urinary glucose excretion. Periodic renal assessment is recommended. Through Pharmatradz.com, B2B pharmaceutical buyers can source Canagliflozin from globally audited manufacturers and exporters, ensuring compliance with USA FDA and EU EMA regulatory standards.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Premixed Insulins (70/30, 50/50) Injectable

Strength: U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details Get Enquiry
Insulin Lispro (Humalog) injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)

View Details Get Enquiry
Insulin Aspart (Novolog) injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Novolog, Fiasp(US &EU)

View Details Get Enquiry
Insulin Glargine (Lantus) injectable

Strength: U-100, U-300

Form: Vials/pens

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.